Mersana Therapeutics Inc
MRSN28.920USD
-0.020-0.07%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
144.56MMarket Cap
LossP/E TTM
Mersana Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
40.50M
9.88%
EPS(YoY)
-14.12
-854.79%
Analyst Rating
HOLD
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its total revenue reached 40.50M, with a year-on-year change of 9.88%.
What is the Earnings Per Share (EPS) of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -14.116, with a year-on-year change of -854.79%.
What is the net income of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its net income was -69.19M, with a year-on-year change of 59.69%.
What is the net margin of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its net profit margin was -170.86%, with a year-on-year change of 63.32%.
What is the gross margin of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 16.25%, with a year-on-year change of 44.44%.
What is the Return on Equity (ROE) of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -505.14%, with a year-on-year change of -89.74%.
What is the Return on Assets (ROA) of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -37.33%, with a year-on-year change of 39.07%.
What is the operating profit of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its operating profit was -73.34M, with a year-on-year change of 57.10%.
What are the current assets of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its current assets were 136.90M, with a year-on-year change of -36.04%.
What are the total assets of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its total assets of Mersana Therapeutics Inc were 144.66M, with a year-on-year change of -36.01%.
What are the total liabilities of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its total liabilities of Mersana Therapeutics Inc were 154.17M, with a year-on-year change of -18.49%.
What is the total equity of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its total equity of Mersana Therapeutics Inc was -9.51M, with a year-on-year change of -125.77%.
What is the net operating income of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its net operating income of Mersana Therapeutics Inc was -69.19M, with a year-on-year change of 59.69%.
What is the net investment of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its net investment of Mersana Therapeutics Inc was 11.44M, with a year-on-year change of -90.46%.
What is the net financing of Mersana Therapeutics Inc?
According to Mersana Therapeutics Inc's FY2024 earnings report, its net financing of Mersana Therapeutics Inc was 4.09M, with a year-on-year change of -95.68%.
